Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL

Clinical trial NCT06641024 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06641024
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, in Relapse Refractory Acute Lymphoblastic Leukemia

Start date: 2024-11-01
Primary completion: 2027-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.